173 related articles for article (PubMed ID: 12960172)
1. Cloning and characterization of ALX, an adaptor downstream of CD28.
Greene TA; Powell P; Nzerem C; Shapiro MJ; Shapiro VS
J Biol Chem; 2003 Nov; 278(46):45128-34. PubMed ID: 12960172
[TBL] [Abstract][Full Text] [Related]
2. The ALX Src homology 2 domain is both necessary and sufficient to inhibit T cell receptor/CD28-mediated up-regulation of RE/AP.
Shapiro MJ; Powell P; Ndubuizu A; Nzerem C; Shapiro VS
J Biol Chem; 2004 Sep; 279(39):40647-52. PubMed ID: 15284240
[TBL] [Abstract][Full Text] [Related]
3. The carboxyl-terminal segment of the adaptor protein ALX directs its nuclear export during T cell activation.
Shapiro MJ; Chen YY; Shapiro VS
J Biol Chem; 2005 Nov; 280(46):38242-6. PubMed ID: 16169852
[TBL] [Abstract][Full Text] [Related]
4. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells.
Tao L; Wadsworth S; Mercer J; Mueller C; Lynn K; Siekierka J; August A
Biochem J; 2002 Apr; 363(Pt 1):175-82. PubMed ID: 11903060
[TBL] [Abstract][Full Text] [Related]
5. The related adaptors, adaptor in lymphocytes of unknown function X and Rlk/Itk-binding protein, have nonredundant functions in lymphocytes.
Perchonock CE; Pajerowski AG; Nguyen C; Shapiro MJ; Shapiro VS
J Immunol; 2007 Aug; 179(3):1768-75. PubMed ID: 17641043
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line.
Irvin BJ; Williams BL; Nilson AE; Maynor HO; Abraham RT
Mol Cell Biol; 2000 Dec; 20(24):9149-61. PubMed ID: 11094067
[TBL] [Abstract][Full Text] [Related]
7. Negative regulation of interleukin-2 and p38 mitogen-activated protein kinase during T-cell activation by the adaptor ALX.
Perchonock CE; Fernando MC; Quinn WJ; Nguyen CT; Sun J; Shapiro MJ; Shapiro VS
Mol Cell Biol; 2006 Aug; 26(16):6005-15. PubMed ID: 16880512
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of TCR signaling by linker for activation of X cells via phosphotyrosine-dependent and -independent mechanisms.
Shapiro MJ; Nguyen CT; Aghajanian H; Zhang W; Shapiro VS
J Immunol; 2008 Nov; 181(10):7055-61. PubMed ID: 18981125
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation at serine 318 is not required for inhibition of T cell activation by ALX.
Shapiro MJ; Spruce L; Sundsbak R; Thapa P; Shapiro VS
Biochem Biophys Res Commun; 2010 Jun; 396(4):994-8. PubMed ID: 20471366
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor of activated T cells and AP-1 are insufficient for IL-2 promoter activation: requirement for CD28 up-regulation of RE/AP.
Shapiro VS; Mollenauer MN; Weiss A
J Immunol; 1998 Dec; 161(12):6455-8. PubMed ID: 9862666
[TBL] [Abstract][Full Text] [Related]
11. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
Nolz JC; Fernandez-Zapico ME; Billadeau DD
J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
[TBL] [Abstract][Full Text] [Related]
12. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28.
Fraser JD; Weiss A
Mol Cell Biol; 1992 Oct; 12(10):4357-63. PubMed ID: 1328852
[TBL] [Abstract][Full Text] [Related]
13. Itk Promotes the Integration of TCR and CD28 Costimulation through Its Direct Substrates SLP-76 and Gads.
Hallumi E; Shalah R; Lo WL; Corso J; Oz I; Beach D; Wittman S; Isenberg A; Sela M; Urlaub H; Weiss A; Yablonski D
J Immunol; 2021 May; 206(10):2322-2337. PubMed ID: 33931484
[TBL] [Abstract][Full Text] [Related]
14. TAK1-mediated transcriptional activation of CD28-responsive element and AP-1-binding site within the IL-2 promoter in Jurkat T cells.
Sakurai H; Singhirunnusorn P; Shimotabira E; Chino A; Suzuki S; Koizumi K; Saiki I
FEBS Lett; 2005 Dec; 579(29):6641-6. PubMed ID: 16293250
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS).
Harada Y; Ohgai D; Watanabe R; Okano K; Koiwai O; Tanabe K; Toma H; Altman A; Abe R
J Exp Med; 2003 Jan; 197(2):257-62. PubMed ID: 12538664
[TBL] [Abstract][Full Text] [Related]
16. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.
Shapiro VS; Truitt KE; Imboden JB; Weiss A
Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of activation of transcription factor AP-1 by CD28 signalling in human T-cells.
Los M; Dröge W; Schulze-Osthoff K
Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):119-23. PubMed ID: 8067997
[TBL] [Abstract][Full Text] [Related]
18. Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element.
Crist SA; Griffith TS; Ratliff TL
J Biol Chem; 2003 Sep; 278(38):35950-8. PubMed ID: 12855690
[TBL] [Abstract][Full Text] [Related]
19. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities.
Michel F; Attal-Bonnefoy G; Mangino G; Mise-Omata S; Acuto O
Immunity; 2001 Dec; 15(6):935-45. PubMed ID: 11754815
[TBL] [Abstract][Full Text] [Related]
20. GRID: a novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28.
Ellis JH; Ashman C; Burden MN; Kilpatrick KE; Morse MA; Hamblin PA
J Immunol; 2000 Jun; 164(11):5805-14. PubMed ID: 10820259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
